mRNA Archives -

News/ News/ R&D

Moderna’s HIV vaccine prepped for trials in Africa

Phil Taylor HIV, infectious disease, Moderna, mRNA, vaccine 0 Comment

Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV

Moderna’s HIV vaccine prepped for trials in Africa

https://pharmaphorum.com/news/modernas-hiv-vaccine-prepped-for-trials-in-africa/

News/ News/ Oncology

AACR: BioNTech finds value in CAR-T/mRNA vaccine combo

Phil Taylor BioNTech, CAR-T therapies, claudin-6, immuno-oncology, mRNA, Oncology 0 Comment

Adding an mRNA vaccine to CAR-T cell therapy could be the key to unlocking activity in solid tumours,

AACR: BioNTech finds value in CAR-T/mRNA vaccine combo

https://pharmaphorum.com/news/aacr-biontech-finds-value-in-car-t-mrna-vaccine-combo/

News/ News/ Sales and Marketing

Alnylam sues Pfizer, Moderna over COVID-19 vaccines

Phil Taylor Alnylam Pharmaceuticals, BioNTech, coronavirus, COVID-19, COVID-19 vaccine, drug delivery, Moderna, mRNA, patent litigation, Pfizer 0 Comment

Alnylam claims it is owed a slice of the massive revenues booked by Pfizer and Moderna for their

Alnylam sues Pfizer, Moderna over COVID-19 vaccines

https://pharmaphorum.com/news/alnylam-sues-pfizer-moderna-over-covid-19-vaccines/

News/ News/ R&D

Moderna targets 15 pathogens in ‘global public health strategy’

Phil Taylor emerging markets, infectious disease, Moderna, mRNA 0 Comment

Moderna has unveiled plans to start clinical trials of mRNA-based vaccines for 15 infectious diseases that pose the

Moderna targets 15 pathogens in ‘global public health strategy’

https://pharmaphorum.com/news/moderna-targets-15-pathogens-in-global-public-health-strategy/

Molecular Genetic Therapy Science Biotechnology

R&D/ Views & Analysis/ Views and analysis

WHO announces international hub for mRNA vaccine training

Jessica Hagen biomanufacturing, COVID-19, Moderna, mRNA, Pfixer, Sourh Korea, World Health Organisation 0 Comment

The World Health Organization (WHO) announced the opening of a global biomanufacturing hub located in South Korea to

WHO announces international hub for mRNA vaccine training

https://pharmaphorum.com/views-and-analysis/who-announces-international-hub-for-mrna-vaccine-training/

Events/ Events

LNP Formulation and Process Development in Pharma | April 12-14 2022

Molly Sullivan Lipid Nanoparticles, LNP, mRNA, Oligonucleotides, rna 0 Comment

Embrace Technology Innovations to Optimise LNP Formulation, Alternative LNP Raw Materials, Process Control to Achieve Seamless Scale-Up, Compliance

LNP Formulation and Process Development in Pharma | April 12-14 2022

https://pharmaphorum.com/events/lnp-formulation-and-process-development-in-pharma-april-12-14-2022/

News/ News/ Patients

Pfizer, Moderna are prepping new vaccines for Omicron

Phil Taylor coronavirus, COVID-19, COVID-19 vaccine, Moderna, mRNA, Omicron, Pfizer 0 Comment

With evidence growing that the current crop of COVID-19 vaccines are less protective against infection with Omicron, both

Pfizer, Moderna are prepping new vaccines for Omicron

https://pharmaphorum.com/news/pfizer-moderna-are-prepping-new-vaccines-for-omicron/

R&D/ Views & Analysis/ Views and analysis

Beyond the pandemic: the potential of mRNA technology

Ben Hargreaves BioNTech, COVID-19, Moderna, mRNA, Pfizer, vaccines 0 Comment

The arrival of COVID-19 brought precious few positives, but one that emerged for the pharmaceutical industry was the

Beyond the pandemic: the potential of mRNA technology

https://pharmaphorum.com/r-d/beyond-the-pandemic-the-potential-of-mrna-technology/

News/ News/ Sales and Marketing

Another mRNA company gets snapped up as Merck buys Exelead

Phil Taylor Exelead, M&A, Merck KGaA, mRNA, outsourcing 0 Comment

The latest pharma company to make a move for an mRNA specialist is Germany’s Merck KGaA, which has

Another mRNA company gets snapped up as Merck buys Exelead

https://pharmaphorum.com/news/another-mrna-company-gets-snapped-up-as-merck-buys-exelead/

Trending

mRNA

Login